Site Map | Yaz and Yasmin Lawsuit Information | Information about Yaz and Yasmin Lawsuit

Yaz Information

Yasmin Information

Ocella, Zarah & Gianvi


Home How We Can Help Case Evaluation FDA Warnings Contact Us Yaz / Yasmin Yaz Information Yasmin Information Ocella, Zarah & Gianvi Side Effects Pulmonary Embolism Yasmin Stroke Deep Vein Thrombosis Yaz Stroke Organ Failure Lawsuit Information Attorney Profiles Yaz Blog Categories Advertising bellwether trials deep vein thrombosis Facebook FDA FDA Warnings gallbladder disease Gianvi heart attack Label MDL Medical Article New Jersey Consolidation Ocella Pennsylvania Consolidation Pulmonary embolism Scientific Studies settlement side effects stroke Teva Pharmaceuticals Venous thromboembolism Watson Laboratories Yasmin Yasmin attorney Yasmin lawsuit Yasmin lawyer Yaz Yaz attorney Yaz lawsuit Yaz lawyer Zarah 2012 January MDL Judge Appoints Special Master to Mediate Yaz/Yasmin Cases 2011 November New Article Suggests Bayer May Have Promoted Yaz/Yasmin for Unapproved Use New Study of Irsaeli Women Reveals Increased Risk of DVT and Pulmonary Embolism in Yaz/Yasmin Users October Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz New Danish Study Confirms Increased Risk of Venous Thromboembolism in Yaz / Yasmin Users September FDA to Convene Panel to Weigh Risks of Yasmin and Yaz August Judge Says He Will Push Settlement Negotiations Following Bellwether Trials Bellwether Trial Schedule Set for New Jersey Litigation June MDL Bellwether Trial Schedule Set FDA Warns of Increased Risk of Blood Clots with Yaz and Yasmin April Two New Articles Confirm Increased Risk of Venous Thromboembolism in Yaz & Yasmin Users Yaz/Yasmin May Put Women at Increased Risk for Gallbladder Disease January Bellwether Trial Schedule Established for Yaz, Yasmin Cases in Pennsylvania 2010 December First Yaz Case Will Involve Pulmonary Embolism November Preliminary Yaz/Yasmin Bellwether Case Selections Completed October First Yaz Case to Trial September 12, 2011 September New Yasmin Generic Approved by FDA Yaz, Yasmin Lawsuits Continue to Flood into Courts August Yaz Lawsuits Moving Forward in Federal Court New Report Shows Industry Funded Studies More Likely to Have Positive Outcome July Number of Yaz, Yasmin, Ocella, Gianvi Lawsuits Continues to Grow Signs You Are Having a Stroke While Taking Yaz, Yasmin, Ocella or Gianvi June The Yaz Lawyers on Facebook Lawsuit Filed Over Launch of Generic Yaz Birth Control Pill Gianvi by Teva Pharmaceuticals Yaz/Yasmin Lawsuits Moving Forward May Lawsuits Against Bayer Continue to Mount April Bayer Updates Labels for Yaz and Yasmin January Yaz/Yasmin MDL Status Conference Today 2009 December Debate Over Contraceptive Questions Major Issue in Pennsylvania Hearing Consumer Advocacy Group Warns to "Think Twice" About Yasmin Yaz Blog November Bayer Continues Agressive Advertising of Yaz New Jersey Courts seek Mass Tort Statuts for Yaz, Yasmin and Ocella Lawsuits October Swissmedic Releases Report on Venous Thromboembolism Caused by Yaz and Yasmin Site Map

The information on this Yasmin & Yaz Attorney / Side Effects Lawyer website is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. This information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship.

Toll Free: 888-338-0283

Jackson Allen Williams, LLP's Principal Office is in Dallas, Texas
The attorney in charge of this web site is John H. Allen, III - john@theyazlawyers.com